W hI located on the gastric reglm, for I hour before and after feeding a 300 cal mxed solid llquld meal [bread, egg, apple juice). Electrcqastrcqraphy (EGG1 slgnals uere recarded on a Reega tlinlhult Tr Alvar polygraph I l a w and upper cutoff freguencles: 0.16 Hz and 30 Hz respectlvelyl and later dig~tized on W3E52R and stored an W Vectra RSBO for spectral analy-515. Results: durlng fastlng, 7 pts Igrwp R) had slgnlficant electrlcal dysrhythnlas I! 10% of the rec&d~ng perlodl such as tachygastr~a I S W between 4 and 9 cpn, u~th regular rhythml, tachyarrhythm~a (SU b e t m 4 and 9 cpa, with Irregular rhythm), bradygastria I SY ( 3 cpll, or flatline patterns; m t dysrhythmc perlds *we coincident w~th dyspeptic syrqtcms such as nausea, epigastric pain and vomlt~ng. In 4 pts (group 81 electr~cal abnornalltie *we rarely detected, as well as In 5 age matched controls (7.1i 3.7 years). llftw feed~ng, only 3 group R pts had marked dysrhythmlas. In all group R pts, antro-dudenal manonetry, perfwaed by perfused catheter, shwd severe w t a changes such as fast~ng and/or fed decreased andlor ~ncwrdinated gastrointestinal mtllity; no d~sturbed mtility "as recorded in grwp B pts. Furtherme, gastric eaptying t~r e In1n.1 (meanfSD1, aeasured by ultrasoncqraphy after eatlng the saae meal adalnlstered during EGG, uas luch m e delayed In group R pts (1137f45.3; range:
K i n d e r k l i n i k u n d 1 n s t . f . K l i n . C h e m i e M e d i z i n i s c h e H o c h s c h u l e t I a n n o v e r T h e a s s e s s m e n t o f s h o r t t e r m (< 1 2 0 d a y s ) p r o g n o s i s i s e s s e n t i a l f o r c h o o s i n g t h e n e x t r e c i p i e n t f o r t r a n sp l a n t a t i o n . I n a p r o s p e c t i v e s t u d y w e a n a l y s
e d t h e p r og n o s t i c v a l u e o f a ) c l i n i c a l s y m p t o m s ( a s c i t e s , n u t r i t io n a l s t a t u s ) , b ) c l i n i c a l -c h e m i c a l tests ( s e r u m b i l i r ub i n , -a l b u m i n , a c t i v i t y o f c h o l i n e s t e r a s e a n d a l k . P h o s p ha t a s e ) a n d c ) l i v e r f u n c t i o n t e s t s ( i n d o c y a n i n e g r e e n t 1 / 2 , ( I C G ) a n d monoethylglycinexylidide ( M E G X ) f o r m a t i o n a f t e r l i d o c a i n e b o l u s i n j e c t i o n ( l m g / k g ) ) ( l ) . T h e p at i e n t s s t u d i e d s u f f e r e d f r o m c i r r h o s i s d u e t o b i l i a r y a t r e s i a ( n = 2 1 ) a n d p o s t n e c r o t i c c i r r h o s i s ( n = 3 3 ) . T h e
m e d i a n a g e w a s 6 y . t h e 16'' -8 4 M p e r c . b e i n g 1 -1 5 y .
T h e v a r i a b l e s a -c ) ' w e r e u s e d as c o v a r i a t e s i n t h e C o x p r o p o r t i o n a l h a z a r d r e g r e s s i o n m o d e l (BMDP 2 1 ) .
T h e r e s u l t s o f MEGX-and ICG t e s t w e r e s i g n i f i c a n t l y rel a t e d t o t h e 120-day s u r v i v a l w i t h o u t t r a n s p l a n t a t i o n ( x L -t e s t ) . T h e a p p r o x i m a t e d x ' -v a l u e s t o e n t e r t h e a n al y s i s s h o w e d c o m p a r a b l e r e s u l t s f o r ICG ( 2 6 . 0 ) a n d ME-GX ( 2 3 . 2 ) . T h e v a l u e s o f t h e o t h e r p a r a m e t e r s w e r e d i st i n c t l y 1 o w e r . N o n e of t h e s e p a r a m e t e r s e v a l u a t e d c o nt r i b u t e d t o a f u r t h e r r e l e v a n t i m p r o v e m e n t o f t h e p r ed i c t i v e a b i l i t y w h e n a d d e d t o t h e v a l u e s o f ICG ( i m p r ov e m e n t p < o . 0 0 0 5 ) a n d MEGX ( i m p r o v e m e n t p r 0 . 0 0 2 ) s u g g es t i n g t h a t t h e s e t e s t s are t h e best s h o r t t e r m p r o g n o st i c i n d i c a t o r s . 1 ) T r a n s p l a n t P r o c 1 9 , 3 8 3 8 , 1 9 8 7 3a S. c a d r a n e l , ~. G o v e n s , 5 . Zeghlache F r e e U n i v e r s i t y of B r u s s e l s Treatment with c o l l o i d a l bismuth s u b c i t r a t e (CBS) a s s o c i a t e d w i t h a m o x y c i l l i n h a s proved t o be e f f e c t i v e i n c l e a r i n g HP a s w e l l a s i n r e d u c i n g t h e r e -i n f e c t i o n r a t e i n a d u l t s . Few a u t h o r s have e x p e r i e n c e d t h i s a s s o c i a t i o n i n c h i l d r e n because of t h e concern about bismuth s a l t s t o x i c i t y i n t h i s age group. I n t h i s s t u d y we have been t r e a t i n g HP i n f e c t i o n i n 44 c h i l d r e n w i t h primary u l c e r o r g a s t r i t i s w i t h 50 mglkgld a m o x y c i l l i n f o r one week a s s o c i a t e d w i t h e i t h e r 8 mg/kg/d CBS o r w i t h a placebo f o r f o u r weeks. Bismuth was assayed by atomic mass s p e c t r o m e t r y (Gist-Brocades Pharma) i n hlood samples b e f o r e , d u r i n g and one o r two weeks a f t e r t h e end of t r e a t m e n t . R e s u l t s : amox + CBS amox + placebo n r p a t i e n t s 23 21 e r a d i c a t i o n of HP 1 0 1 c l i n i c a l l y improved 12 8 no change 1 1 2 Bismuthemia remained below 20 p g / l i n a l l but 3 p a t i e n t s a t 3-4 weeks (bismuth l e v e l s 25-28 p g / l ) and i n 1 a t 8 weeks (50 )~g / l ) who had been t a k i n g e r r o n e o u s l y a double dosage. No s i g n s of t o x i c i t y were recorded though c o n s t i p a t i o n was n o t i n f r e q u e n t . Low bismuthemias a t 4 weeks a r e due t o poor compliance i n many p a t i e n t s . A f t e r t h e end of t h e t r e a t m e n t bismuth l e v e l s d e c r e a s e d g r a d u a l l y ( b u t s l o w l y ) i n a l l a s s a y s . Conclusion: These a r e t h e f i r s t r e s u l t s o f Bismuthemias r e p o r t e d i n c h i l d r e n . Therapy w i t h CBS seems s a f e . However compliance f o r long t r e a t m e n t s i s not s u f f i c i e n t i n c h i l d r e n . It has been reported (Lancet 1987; ii: 877-880 ) that recombinant interferon alpha (riFN-a) is not useful in Chinese children with chronic hepatitis 8. We carried out a controlled study in Caucasian children. We included 36 children (mean a g e 8.2 years) with a n histologically proven chronic hepatitis. All of them were HBsAg, HBeAg and HBV-DNA positive for at least 1 year before entry into the study. All the children were anti-HD and anti-HIV-I negative. They were randoply allocated to one of the following groups: group 1) 12 children received 10 MU/m b.s. of rlFN-a 2b (Intron A) subculaneously thrice weekly for 6 months; group 11) 12 children received 5 MU/m b.8. under the same schedule: group 111) 12 children, control without treatment. No basal differences between the three groups were observed with respect to age, sex, ALT, etc.
The treatment was well tolerated and ail children completed the therapy period. Side effects included flu-like syndrome, anorexia, myalgia, neutropenia and moderate thrombooenia.
At the end ol the treatment period. HBV-DNA became negative in 7 patienls (59%) from Group i and 5 cases (42%) from Group II a s compared t o 2 (17%) from the control arouo lo < 0.05). This situation remained unchanged until the end of the trial (1 year( H B~A~ was negative in 33% of the treated patienis and only in 8% of the controls. The ALT was normal in 21% ol the treated children and in 8% of the controls. Anti-IFN-a antibodies (as detected by ELISA) developed in 8 patients (4 with and 4 without HBV-DNA) and remained posilive at the end of the treatment period.
In summary, therapy with rlFN-a in children is well tolerated. Cualitative changes in lectin binding characteristics in cwliac disease hart been previously &scribed (Histochetistry 18, 101, 19%1) ; in particular, the expression of PYA binding (611-GalWac residues) in goblet cells of cwliac tucosa appears to be as itportant point of histochetical difference betrem caliac and cpntrol nucwae. In order to verify rhetkr this PHI reaitivib is ncdified in culture systet,rith and rithout l k additipn of a peptic-tryptic digest of A-gliuin (PI) at a c0n:entration of 0.1 tg/nl.re hare studied I cases of untreated cwliac nucosae placed in culture for 30 h in a rerun-containing adiut.lll !win's solution-fixed paraffin-enbedded sections rere incubated rith PHL-HRP conjugated Iectin (Siqna Chenical Co.) as extensively elserhcre reported (Histocknistry 88,IOI,L9%l);prior to staining rith PWL,parallel sections rere digested rith neuraninidase frot Vibrio Cholerae (Calbicchan Corp.) (Lab Invest 41,18S,1981) .Adequale control procedures rere also carried aut.
flat intestinal nueosa fron a11 caliac patients underrant a clear norpholqical inprovetent rhen cultured for SO h in t k absence of ?I and enterocyte height us considerablj increased after culture.lhen the tissue culture mas perforted in t k presence of P1,m aorpho1cqical or 10rphOaetric inprovenrnt r e observed and wcrotic areas and cell debris rere fwd. An evident PI A reactivity ma 5 observed in thc supranuclear region of entertrytes of regenerating tucuae ad also in u s l t s treated rith PI;this PWL reactive pattern is unncdified by neuraninidase pretreatnent.lnflannatory cells in t k latina propria are greatly slrined after neuratinidase digestipn.ln uneulturcd unples of dhm-jtjuul biopsies fron sane patients.wly goblet cells rere reactire.lhertfore re cpntend that untreated csliac tucosae in culture systet express ner P W i binding sites as a consequence of punlitatire changes in glycoproteins synthesis and sicretipn.as previously reported(6Ul IO,III9.I989);tk unncdified ?WI pattern after neuraninidase digestion nay sugqesl an altered qlycwilation in entertrytes sire sialic acid grows are not incorwrated or lacking in oligonccharidc chains.
